CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total		Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ (62,308)			$ 3	$ 1,403	$ (63,714)
Beginning balance, shares at Dec. 31, 2020			23,978,747
Beginning balance at Dec. 31, 2020			$ 121,080
Beginning balance, Shares at Dec. 31, 2020				2,712,694
Conversion of redeemable convertible preferred shares into common stock	121,080			$ 24	121,056
Conversion of redeemable convertible preferred shares into common stock, shares			(23,978,747)
Conversion of redeemable convertible preferred shares into common stock			$ (121,080)
Conversion of redeemable convertible preferred shares into common stock, shares				23,978,747
Conversion of convertible notes into common stock	24,982			$ 2	24,980
Conversion of convertible notes into common stock, shares				1,470,947
Issuance of common stock upon IPO, net of issuance costs	159,899			$ 10	159,889
Issuance of common stock upon IPO, net of issuance costs, shares				10,350,000
Issuance of common stock upon exercise of stock options	190				190
Issuance of common stock upon exercise of stock options, shares				172,158
Stock-based compensation	1,473				1,473
Net loss	(29,516)					(29,516)
Ending balance at Jun. 30, 2021	215,800			$ 39	308,991	(93,230)
Ending balance, Shares at Jun. 30, 2021				38,684,546
Beginning balance at Mar. 31, 2021	230,912			$ 39	307,903	(77,030)
Beginning balance, Shares at Mar. 31, 2021				38,550,148
Issuance of common stock upon exercise of stock options	143				143
Issuance of common stock upon exercise of stock options, shares				134,398
Stock-based compensation	945				945
Net loss	(16,200)					(16,200)
Ending balance at Jun. 30, 2021	215,800			$ 39	308,991	(93,230)
Ending balance, Shares at Jun. 30, 2021				38,684,546
Beginning balance at Dec. 31, 2021	188,803	[1]		$ 40	317,304	(128,541)
Beginning balance, Shares at Dec. 31, 2021				39,663,645
Net loss	13,100
Ending balance at Mar. 31, 2022	204,632			$ 40	320,055	(115,463)
Ending balance, Shares at Mar. 31, 2022				39,850,088
Beginning balance at Dec. 31, 2021	188,803	[1]		$ 40	317,304	(128,541)
Beginning balance, Shares at Dec. 31, 2021				39,663,645
Issuance of common stock warrants in connection with the term loan	494				494
Issuance of common stock upon exercise of stock options	$ 121				121
Issuance of common stock upon exercise of stock options, shares	60,494			60,494
Issuance of common stock under employee stock purchase plan	$ 300				300
Issuance of common stock under employee stock purchase plan, shares				77,811
Issuance of common stock for settlement of restricted stock units, Shares				279,514
Stock-based compensation	3,948				3,948
Net loss	(8,599)					(8,599)
Ending balance at Jun. 30, 2022	185,067			$ 40	322,167	(137,140)
Ending balance, Shares at Jun. 30, 2022				40,081,464
Beginning balance at Mar. 31, 2022	204,632			$ 40	320,055	(115,463)
Beginning balance, Shares at Mar. 31, 2022				39,850,088
Issuance of common stock upon exercise of stock options	29				29
Issuance of common stock upon exercise of stock options, shares				15,314
Issuance of common stock for settlement of restricted stock units, Shares				216,062
Stock-based compensation	2,083				2,083
Net loss	(21,677)					(21,677)
Ending balance at Jun. 30, 2022	$ 185,067			$ 40	$ 322,167	$ (137,140)
Ending balance, Shares at Jun. 30, 2022				40,081,464

[1] The balance sheet as of December 31, 2021 is derived from the audited financial statements as of that date